Effects of Reminiscence Therapy on Cognition, Depression and Quality of Life in Elderly People With Alzheimer's Disease: A Systematic Review of Randomized Controlled Trials
Journal of Clinical Medicine
Cammisuli, D. M., Cipriani, G., et al. (2022).
Journal of Clinical Medicine, 11(19), 5752.
This systematic review explores the effects of reminiscence therapy on cognition, depression, and quality of life in patients over the age of 65 who have been diagnosed with Alzheimer's disease.
Italian Ministry of Health
From database inception to July 5, 2022
Randomized controlled trials
5
Findings "globally showed that RT [reminiscence therapy] both administered in individual or group sessions at least once a week for 30–35 min over a period of 12 weeks is effective in supporting global cognition, ameliorating depression, and improving specific aspects of the QoL in elderly people with AD" (p. 7). Limitations to this review include an overall paucity of research and limited investigation into maintenance of gains. Further research is indicated.
